Tom Flaig, MD Chairs the NCCN Bladder Panel.
Consisting of 49 clinicians and basic scientists, the prestigious NCCN bladder panel meets at least twice yearly two review the latest advances in bladder cancer research. The NCCN practice guidelines are the “bible” for oncologists around the world to find the most reliable and current recommendations for treating bladder cancer.
About NCCN
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of 30 leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, efficient, and accessible cancer care so patients can live better lives. Through the leadership and expertise of clinical professionals at NCCN Member Institutions, NCCN develops resources that present valuable information to the numerous stakeholders in the health care delivery system
Bladder Cancer Patient Guidelines
Patients, too, can find the latest information on bladder cancer at NCCN. Click here to download a PDF file.
Did you know?
The American Cancer Society’s estimates for bladder cancer in the United States for 2020 are:
About 81,400 new cases of bladder cancer (about 62,100 in men and 19,300 in women)
About 17,980 deaths from bladder cancer (about 13,050 in men and 4,930 in women)
The rates of new bladder cancers and deaths linked to bladder cancer and have been dropping slightly in women in recent years. In men, incidence rates have been decreasing, but death rates have been stable.
Bladder cancer is the fourth most common cancer in men, but it's less common in women.
Find Bladder Cancer Clinical Trials
The most comprehensive listing of bladder cancer clinical trials is at Clinicaltrials.gov. Use the website to keep up on the rapidly changing research for this cancer type.
